BIOTHERAPEUTICS DEVELOPABILITY
AND RISK MITIGATION
Download the Sponsor/Exhibitor opportunities HERE
Pierre-Mehdi Hammoudi
17 rue Crépet
69007 Lyon
+33 (0)4 78 02 39 89
pierre-mehdi.hammoudi@mabdesign.fr
www.mabdesign.fr
BIOPC2024
BIOPC – Terms & conditions – Cookies – Design by IGTech
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientifi c innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 100,000 people at Sanofi are dedicated to make a diff erence on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
SGS’s global network of analytical testing, formulation, clinical research, and clinical manufacturing solutions offer a wide range of integrated services and expertise across America, Europe, and Asia-Pacific. SGS experts are ready to support customers throughout the development and commercial manufacture of their drug products, helping ensure the delivery of safe, effective, and compliant medicines to global markets.
https://www.sgs.com/en/our-services/health-and-nutrition/health-science
With a storage capacity of more than 20 million biological samples, the BioKryo network operates in three European countries, with four dedicated sites. Each site offers a complete range of cryogenic services, including storage temperatures from -196°C to +20°C with all associated services including cryogenic sample transport. This service is destined for research teams in the human and veterinary health sector, pharmaceutical or cosmetic industries, wishing to secure their samples, duplicate their collections or free up space in their premises. Within the BioKryo network, all processes and quality systems are harmonized to meet the highest quality and safety standards for diagnostic, research and therapeutic purposes, wherever a sample is stored. Sample monitoring and traceability is ensured 24/7/365 in a doubled and automatic control by teams of technicians and biologists. All sites comply with Good Manufacturing Practices (GMP) for the reception, storage and provision of biological samples.
SANI Membranes is Danish cleantech company, and the inventor of the Vibro® technology. The Vibro® technology is used in biopharma, ingredients, food and dairy industries for filtration, separation, clarification and concentration. Primary applications are processing of all kinds of cell cultures, proteins, enzymes and separation of target molecules.
Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. The company holds a unique place on the market with all of its laboratories on one site, 250 highly-qualified professionals and more than 40 years’ at the forefront of analytical sciences. We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences. For each customer and each project, we design customised solutions, define analytical protocols, develop and validate specific new analytical methods and perform characterisation, stability, pharmacokinetic, biomarker and immunogenicity studies as well as batch release testing, in order to evaluate the Quality, Safety and Efficacy of the given drugs.
PathoQuest is a global leader in the provision of GMP grade NGS-based testing services to the biopharmaceutical industry. With facilities in Europe and the US, our proprietary assays and bioinformatic approaches accelerate adventitious agent detection and bioprocess characterization, enabling the safe and high-quality production of biopharmaceuticals and replacing animal testing.
Promepla – Your innovation booster for single-use solutions.
From design and development up to the manufacturing and sterilization, Promepla is your one-stop-shop partner to move forward with.
Promepla brings its support from early stages of design and development of single-use biopharm solutions, providing high-end overall service.
Injection molding, customized single-use components and assemblies, clean room manufacturing, QA/RA support : our experts are present with you to enhance your experience.
Partnership, flexibility and agility: the key-words for your partnership with Promepla.
Quantoom Biosciences is reinventing mRNA production by developing an RNA Platform (NfinityTM) that encompasses DNA (NplifyTM) and RNA (NtensifyTM) manufacturing and formulation (NcapsulateTM), along with critical reagent supply, from small to larger scale, ideally for pre-clinical and clinical study or trial projects. We are a team of scientists, engineers and clinicians committed to solving some of the biggest DNA and RNA production challenges facing vaccines and therapeutics, by delivering greater access and autonomy to mRNA technology. Our facilities are strategically located in Belgium and France, in the heart of Europe, benefiting from an exceptional biotech ecosystem. Quantoom Biosciences is part of Univercells, a global life sciences Group with the mission of making biologics accessible to all.
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimize workflows.
Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
Our Life Science activity supports you with its range of Applikon bioreactors for your applications, from research to production.
Greiner Bio-One is a member of Greiner AG. Founded in 1868, Greiner AG is a family-owned German company specializing in techno-polymers. Greiner Bio-One is an international medical technology company, present in over 100 countries. The BioScience division has become one of the world’s leading technology partners for universities, research institutes, the pharmaceutical and biotech industries.
RD-Biotech is a biotechnology company that offers tailor-made solutions in Molecular Biology, Immunology and Cellular Engineering, as part of Research & Development, pre-clinical or clinical studies. Since its creation in 2002, RD-Biotech provides technical skills and scientific know-how for a personalized, responsive and quality service, and with complete confidentiality.
RD-Biotech is at your disposal to meet your needs and accelerate your research.
From a feasibility study to the development and production of your biological reagents: DNA, antibodies, recombinant proteins, cells…
The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company’s shares are listed on Nasdaq First North Growth Market. Find more information at Investor Relations.
Genovis’ business concept is to offer customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Genovis enzyme products, known as SmartEnzymes, are used by scientists all over the world and the innovative product formats facilitate development and quality control of biological drugs.
Through the acquisition of QED Bioscience in 2020 the product portfolio has expanded to include antibodies and reagents for use in research, biological drug development and diagnostic assays. Read more about QED at www.qedbio.com
A cornerstone of Genovis’ R&D activities is customer relations that enables product development to meet customer needs. Just as valuable is the collaboration with academic groups that focus on characterizing new enzymes, developing new workflows and antibodies for novel targets.